1-2 of 2
Joyce Juersivich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes

Clinical Trials & Observations
Mikkael A. Sekeres, Ramon V. Tiu, Rami Komrokji, Jeffrey Lancet, Anjali S. Advani, Manuel Afable, Ricki Englehaupt, Joyce Juersivich, David Cuthbertson, Jennifer Paleveda, Ali Tabarroki, Valeria Visconte, Hideki Makishima, Andres Jerez, Ronald Paquette, Alan F. List, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2012) 120 (25): 4945–4951.
https://doi.org/10.1182/blood-2012-06-434639
Published: 2012
Includes: Supplemental data
Journal Articles

Final Results From the Phase 2 Continuation Study of the Lenalidomide and Azacitidine Combination in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

Mikkael A. Sekeres, MD, MS, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Ramon V. Tiu, MD, Anjali S. Advani, MD, Manual Afable, Ricki Englehaupt, Joyce Juersivich, David Cuthbertson, M.S., Jennifer Paleveda, Ronald Paquette, MD, PhD, April Smith, Lori Strozniak, Alan F. List, MD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 607.
https://doi.org/10.1182/blood.V118.21.607.607
Published: 2011